EPO and sickle cell disease: In fact, during these years, Dr. Lin, in addition to cloning human EPO, cloned and helped to produce high levels of recombinant monkey EPO [51], a product with no commercial value per se but that was instrumental for performing pre-clinical studies in the baboons and rhesus monkeys to identify pharmacological treatments for Sickle Cell Disease and Thalassemia [60,161,162].